Egyptian International Pharmaceutical Industries Stock Forecast for 2023 - 2025 - 2030
Updated on 04/15/2024
Egyptian International Pharmaceutical Industries Stock Forecast and Price Target
The average price target of £71.00 for Egyptian International Pharmaceutical Industries's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 60.74% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of £79.60 and a low estimate of £66.00. If you are not interested in PHAR stock, you may be interested in its competitors.
60.74% Upside
Egyptian International Pharmaceutical Industries Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Egyptian International Pharmaceutical Industries's Price has decreased by 100.00%, from £41.15 to £0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach £52.63 – an increase of 100.00%. The Egyptian International Pharmaceutical Industries forecast is for Fair Value to reach £125.87 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMDA Stock Forecast | Tenth of Ramadan for Pharmaceu... | Buy |
14
|
£2.61 | Buy/Sell | £2.38 | 38.31% |
| BIOC Stock Forecast | GlaxoSmithKline S.A.E | - |
14
|
£31.57 | Buy/Sell | £0.00 | -100.00% |
| MIPH Stock Forecast | MINAPHARM Pharmaceuticals | - |
16
|
£225.48 | Buy/Sell | £0.00 | -100.00% |
| OCPH Stock Forecast | October Pharma S.A.E | - |
0
|
£100.00 | Buy/Sell | £0.00 | -100.00% |
| CPCI Stock Forecast | Kahira Pharmaceuticals & Chemi... | - |
0
|
£70.23 | Buy/Sell | £44.00 | -100.00% |
Egyptian International Pharmaceutical Industries Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Egyptian International Pharmaceutical Industries's Revenue has increased by 79.80%, going from £2.91B to £5.23B. For the next year, 2 analysts project Egyptian International Pharmaceutical Industries's Revenue to drop by 0.31%, reaching £5.22B. The Egyptian International Pharmaceutical Industries forecast is for Revenue to reach £15.17B or grow by 190.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NIPH Stock Forecast | The Nile Co. for Pharmaceutica... | - |
0
|
£81.83 | Buy/Sell | £0.00 | -100.00% |
| AXPH Stock Forecast | Alexandria Co. For Pharmaceuti... | - |
0
|
£237.09 | Buy/Sell | £0.00 | -100.00% |
| ADCI Stock Forecast | The Arab Drug | - |
0
|
£78.82 | Buy/Sell | £0.00 | -100.00% |
.jpg)
Egyptian International Pharmaceutical Industries Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Egyptian International Pharmaceutical Industries's Dividend per Share has fallen from £1.50 to £1.00 – a 33.33% decrease. According to 1 prominent analysts, Egyptian International Pharmaceutical Industries's Dividend per Share will fall by 0.00% in the next year, reaching £1.00. Over the next seven years, the pros' prediction is Dividend per Shareof £5.00, which would mean a seven-year growth forecast of 400.00%.
Egyptian International Pharmaceutical Industries EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Egyptian International Pharmaceutical Industries's EBITDA has grown, increasing from £726.89M to £1.31B – a growth of 80.71%. The next year looks promising for Egyptian International Pharmaceutical Industries, with analysts predicting EBITDA of £1.39B – an increase of 5.74%. Over the next seven years, experts anticipate that Egyptian International Pharmaceutical Industries's EBITDA will grow at a rate of 169.12%.
Egyptian International Pharmaceutical Industries EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Egyptian International Pharmaceutical Industries's EBIT has grown by 106.17%, from £587.32M to £1.21B. For the next year, analysts are expecting EBIT to reach £1.29B – an increase of 6.53%. Over the next seven years, experts predict that EBIT will grow by 165.02%.
Egyptian International Pharmaceutical Industries EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Egyptian International Pharmaceutical Industries's EPS has decreased by 100.00%, from £4.91 to £0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach £6.28 – an increase of 100.00%. The Egyptian International Pharmaceutical Industries forecast is for EPS to reach £15.02 or grow by 100.00%.
Site Navigation
.jpg)